Media

G&E Herbal Biotechnology recently won three honors in the 2025 Foreign Investment Taiwan Top 100—Mid-tier Potential Enterprise, Top 10 Growth, and Top 10 Profitability—underscoring its strong market momentum and innovation. With flagship products like the liver-protection drug Hepanamin® and the eye-health supplement SR-100 SolaVision, the company has boosted revenue and consumer recognition. Its patented SR-100 technology, which selectively removes aging and cancerous cells while reducing inflammation, is being applied across anti-cancer, antiviral, anti-aging, and eye-care fields. Looking ahead, G&E Herbal Biotech plans to expand globally, commercialize its core technology, and pursue international clinical validation to position Taiwan’s biotech achievements on the world stage.

SR-100 Core Strengths

✔ Exclusive global invention patent

✔ Patents granted in dozens of countries including the U.S., Japan, South Korea, Germany, the U.K., France, and the EU

✔ Highly effective with noticeable results, achieving breakthrough absorption efficiency

✔ Supported by scientific research, breaking through existing treatment bottlenecks

✔ Manufactured in compliance with PIC/S GMP pharmaceutical standards

✔ Comprehensive and precise health protection with all-round efficacy